Frederico O. Gleber-Netto, D.D.S., MSc, Ph.D.
Department of Head and Neck Surgery, Division of Surgery
About Dr. Frederico O. Gleber-Netto
Dr. Netto is a dentist-scientist who is deeply passionate about cancer research. He brings a wealth of expertise and knowledge to his work, with a diverse background in pathology, biostatistics, and genomics. Dr. Netto's research interests are primarily focused on head and neck tumors and other squamous carcinomas, and his experience extends across a range of disciplines, including surgical and molecular pathology, clinical research, biomarker development, and genomics. Currently, Dr. Netto is particularly interested in the exciting new field of cancer neuroscience, where he is exploring innovative approaches to understanding and treating this complex and challenging disease.
Present Title & Affiliation
Primary Appointment
Assistan Professor, Department of Head and Neck Surgery - Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | AC Camargo Cancer Center, Sao Paulo, BR, Ph.D. in Oncology |
| 2011 | School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, BR, M.S. in Oral Pathology |
| 2008 | School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, BR, DDS in Dental Surgery |
Postgraduate Training
| 2016-2022 | Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Research Internship, UCLA Center of Oral/Head and Neck Research School of Dentistry-University of California Los Angeles, Los Angeles, California |
| 2009-2009 | Research Internship, School of Dentistry-Universidade Federal de Goias, Goiania |
Licenses & Certifications
| 2008 | DDS |
| 2008 | Regional Council of Dentistry of Minas Gerais (Conselho Regional de Odontologia de Minas Gerais, CRO-MG) |
Experience & Service
Faculty Academic Appointments
Instructor, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - 2025
Other Professional Positions
Dentist, General Dental Practice, Belo Horizonte, 2008 - 2009
Undergraduate Researcher, Universidade Federal de Minas Gerais, Belo Horizonte, 2007 - 2009
Undergraduate Researcher, Universidade Federal de Minas Gerais, Belo Horizonte, 2005 - 2007
Extramural Institutional Committee Activities
External member, PhD Qualifying Exam Committee, Universidade Federal de Minas Gerais, 2023
External member, PhD Thesis Committee, Universidade Federal de Minas Gerais, 2018
External member, Master's Dissertation Committee, Universidade Federal de Minas Gerais, 2018
Editorial Activities
Guest Editor, Research Progress of Cutaneous Squamous and Basal Cell Carcinomas (Volume II), 2023 - Present
Guest Editor, Research Progress of Cutaneous Squamous and Basal Cell Carcinomas (Volume I), 2021 - 2022
Editorial Board Member, BMC Cancer, 2020 - Present
Editorial Board Member, Archives in Biosciences & Health, 2018 - Present
Selected Presentations & Talks
Local Presentations
- 2018. Salivary biomarkers. Invited. Joacaba, Santa Catarina, BR.
- 2018. Saliva as a diagnostic tool. Invited. Belo Horizonte, Minas Gerais, BR.
- 2018. Grant application. Invited. Belo Horizonte, Minas Gerais, BR.
- 2018. HPV-related oropharyngeal cancer - Etiology and prognosis. Invited. Joacaba, Santa Catarina, BR.
- 2009. Plexiform neurofibroma - clinical case. Conference. 16th Minas Gerais State Stomatology Symposium, BR.
- 2008. Polymorphous low-grade adenocarcinoma - clinical case. Conference. 15th Minas Gerais State Stomatology Symposium, BR.
National Presentations
- 2013. MMP16 polymorphism as a possible marker of aggressiveness in head and neck squamous cell carcinoma. Poster. Next frontiers to cure cancer - Integrating science and patient care. Sao Paulo, BR.
- 2008. EGFR, HER-2/Neu e Fator de Crescimento Endotelial Vascular C (VEGF-C) em carcinomas de células escamosas bucal. Poster. International Association for Dental Research (IADR). Aguas de Sao Pedro, BR.
- 2007. Estudo clínico, histopatológico e da atividade proliferativa do tumor odontogênico cístico calcificante. Poster. International Association for Dental Research (IADR). Aguas de Sao Pedro, BR.
International Presentations
- 2023. The Neural Landscape is Associated with Functional Outcomes for Patients with Oropharyngeal Squamous Cell Carcinoma. Poster. AACR AHNS. Montreal, CA.
- 2023. The Evolution of the Tumor Immune Microenvironment in Immunosuppressed Patients with Cutaneous Squamous Cell Carcinoma. Poster. AACR AHNS. Montreal, CA.
- 2023. Impact of Perineural Invasion (PNI) in Cutaneous Squamous Cell Carcinoma of the Head and Neck (CSCC-HN). Conference. American Head & Neck Society. Montreal, CA.
- 2019. Variations in the proteasome activity are associated with human papillomavirus (HPV) gene expression and patient survival in HPV+ oropharyngeal tumors. Poster. AACR-AHNS Head and Neck Cancer Conference. Austin, US.
- 2018. Risk stratification and biomarker discovery in HPV-positive oropharynx squamous cell carcinoma determined by HPV and human gene expression profile associations. Poster. American Association for Cancer Research (AACR) 109th Annual Meeting. Chicago, US.
- 2015. Searching for lymph node metastasis biomarkers in oral squamous cell carcinoma using large-scale transcriptional analysis. Conference. 5th World Congress of the International Academy of Oral Oncology. Sao Paulo, BR.
- 2014. Next-generation sequencing indicates putative transcriptional markers of nodal metastasis in oral squamous cell carcinoma. Poster. 5th World Congress of International Federation of Head and Neck Oncologic Societies. New York, US.
- 2012. Analysis of SNPs in metalloprotease-related genes in head and neck squamous cell carcinoma patients. Poster. 16th International Congress on Oral Pathology and Medicine. Aguas de Lindoia, BR.
- 2011. Angiogenesis and lymphangiogenesis in mucoepidermoid carcinoma of the minor salivary glands. Poster. American Association for Cancer Research (AACR) 102nd Annual Meeting. Orlando, US.
Grant & Contract Support
| Date: | 2026 - Present |
| Title: | Serotonin-Driven Mitochondrial Defense for Prevention of Chemobrain |
| Funding Source: | American Cancer Society |
| Role: | PI |
| ID: | FP00028564 |
| Date: | 2026 - Present |
| Title: | Neuroimmune Modulation of Oral Senescence: Exploring the Impact of Sensory Neuronal Signaling on Oral Carcinogenesis |
| Funding Source: | NIH |
| Role: | PI |
| ID: | GRANT14501218 |
| Date: | 2025 - Present |
| Title: | I-PROTECT - Intratumoral Prevention and Risk Outcomes in Targeted Early Cancer Treatment with Immunotherapy |
| Funding Source: | CPRIT |
| Role: | Co-PI |
| ID: | RFA R-26.1-IIRACT |
| Date: | 2025 - 2023 |
| Title: | Decoding L1CAM-EGFR Signaling in Schwann Cells: Unraveling Neuroimmune Interactions in Head and Neck Cancer |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00024377 |
| Date: | 2025 - 2030 |
| Title: | PRECISE-OPMD Trial: Preventing Cancer through Intratumoral Strategy and Early Biomarker Evaluation in Oral Potentially Malignant Disorders |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00022361 |
| Date: | 2025 - 2029 |
| Title: | I-PROTECT - Intratumoral Prevention and Risk Outcomes in Targeted Early Cancer Treatment with Immunotherapy |
| Funding Source: | CANCER PREVENTION RESEARCH INST OF TX |
| Role: | Co-I |
| ID: | FP00022903/RP250354 |
| Date: | 2024 - 2029 |
| Title: | Multidimensional atlas of dynamic cellular, morphologic, and microenvironment changes driving progression of oral potentially malignant disorders |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00021066 |
| Date: | 2024 - 2029 |
| Title: | Defining the Role of Schwann Cell L1CAM-EGFR Signaling in Perineural invasion, Neuroinflammation and Cancer Associated Pain |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00015531_Res1 |
| Date: | 2024 - 2025 |
| Title: | Supplement - Frederico Netto - Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer |
| Funding Source: | NIDCR |
| Role: | Award recipient |
| ID: | 3R01DE032018-03S1 |
| Date: | 2023 - 2024 |
| Title: | Harnessing the nervous system to augment the antitumor immune response |
| Funding Source: | University of Texas |
| Role: | Co-PI |
| ID: | UTMDA_UTA_07272023 |
| Date: | 2022 - 2027 |
| Title: | Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer |
| Funding Source: | NIH |
| Role: | Key |
| ID: | 1R01DE032018 |
| Date: | 2021 - 2026 |
| Title: | CPRIT Early Clinical Investigator Award-Moran Amit - Developing a clinical trial platform for local delivery of immunotherapy |
| Funding Source: | CANCER PREVENTION RESEARCH INST OF TX |
| Role: | Key |
| ID: | RP210176 |
| Date: | 2021 - 2026 |
| Title: | Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders |
| Funding Source: | NIH/NIDCR |
| Role: | Postdoctoral Fellow |
| ID: | R01-DE030656 |
| Date: | 2019 - 2024 |
| Title: | HPV Intrinsic Variability as a Modulator of Oropharyngeal Cancer Biology |
| Funding Source: | NIH/NIDCR |
| Role: | PI |
| ID: | PAR19-144 |
| Date: | 2019 - 2024 |
| Title: | Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma |
| Funding Source: | NIH |
| Role: | Postdoctoral fellow |
| ID: | R01DE028061 |
| Date: | 2019 - 2022 |
| Title: | Genomic Stratification and Targeting of HPV+ Cancer |
| Funding Source: | NIH/NIDCR |
| Role: | Postdoctoral Fellow |
| ID: | R03-DE028381 |
| Date: | 2018 - 2020 |
| Title: | Genomic Stratification of HPV+ Cancer: Risk and Therapeutic Targeting |
| Funding Source: | AACR |
| Role: | PI |
| ID: | BU00006327 |
| Title: | Harnessing Serotonergic Neuroprotection to Prevent Chemotherapy-Related Cognitive Impairment |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| ID: | 6299 |
Selected Publications
Peer-Reviewed Articles
- Liu, N, Shi, X, Chen, S, Chen, H, Santi, MD, Phuong, DM, Fialho, MP, Xie, T, Gleber-Netto, FO, Latorre, R, Bunnett, NW, Viet, CT, Amit, M, Pan, H, Ye, Y. EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. Science signaling 19(922):eadt3026, 2026. e-Pub 2026. PMID: 41592151.
- Zhang, M, Yuan, M, Asam, K, Gong, Z, Xie, T, Gleber-Netto, FO, Santi, MD, Kobayashi, Y, Shimizu, E, Aouizerat, B, Amit, M, Boada, MD, Ye, Y. Perineural Invasion Exhibits Traits of Neurodegeneration. Journal of Dental Research 104(12):1352-1360, 2025. e-Pub 2025. PMID: 40492439.
- Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallon de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature 646(8084):462-473, 2025. e-Pub 2025. PMID: 40836096.
- Yaniv D, Naara S, Netto FOG, Stafford H, Buell J, Chiang E, Shahrukh A, Li S, Nagarajan P, Hanna EY, Gross ND, Amit M. Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant Immunotherapy. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40824417.
- Branco NTT, Rodrigues-Ribeiro L, Almeida NP, Gleber Netto FO, Nogueira FCS, Magalhaes CS, Verano-Braga T, Diniz IMA. Older Adults' Salivary Proteomic Is Reshaped by Caries Disease Severity. Caries Res:1-11, 2025. e-Pub 2025. PMID: 40545808.
- Zhao, M, Wang, T, Gleber-Netto, FO, Chen, Z, McGrail, DJ, Gomez, JA, Ju, Wt, Gadhikar, MA, Ma, W, Shen, L, Wang, Q, Tang, X, Pathak, S, Raso, G, Burks, JK, Lin, S, Wang, J, Multani, AS, Pickering, CR, Chen, J, Myers, JN, Zhou, G. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38167338.
- Islam, S, Gleber-Netto, FO, Mulcahy, CF, Glaun, MD, Srivastava, S, Hunt, PJ, Williams, MD, Barbon, CE, Spiotto, MT, Zhao, W, Adebayo, A, Akhter, S, Xie, T, Debnath, KC, Sathishkumar, HN, Myers, B, Lothumalla, S, Yaman, I, Burks, JK, Gomez, JA, Rao, X, Wang, J, Woodman, K, Mansour, J, Arenkiel, BR, Osman, KL, Haxton, C, Lever, TE, Hutcheson, KA, Amit, M. Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma. Science translational medicine 16(758), 2024. e-Pub 2024. PMID: 39083586.
- Michikawa C, Gleber-Netto FO, Pickering CR, Rao X, Wang J, Sikora AG, Myers JN, Frederick MJ. Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer. Oral Oncol 153:106729, 2024. e-Pub 2024. PMID: 38663156.
- Gleber-Netto FO, Nagarajan P, Sagiv O, Pickering CR, Gross N, Ning J, Yeshi MM, Mitku Y, Tetzlaff MT, Esmaeli B. Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden. Invest Ophthalmol Vis Sci 65(4):24, 2024. e-Pub 2024. PMID: 38597722.
- Zhang, X, Netto, FG, Wang, S, Jin, KW, Yang, DM, Gillenwater, AM, Myers, JN, Ferrarotto, R, Pickering, CR, Xiao, G. A Deep Learning Onion Peeling Approach to Measure Oral Epithelium Layer Number. Cancers 15(15), 2023. e-Pub 2023. PMID: 37568707.
- Baruch EN, Nagarajan P, Gleber-Netto FO, Rao X, Xie T, Akhter S, Adewale A, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich S, Calin GA, Migden MR, Vermeer P, D'Silva N, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Gross ND, Amit M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Res Sq, 2023. e-Pub 2023. PMID: 37503252.
- Chen, Y‐, Zhao, W, Na'ara, S, Netto, FG, Xie, T, Ali, S, Thompson, Z, Buell, J, Stafford, H, Nagarajan, P, Davies, MA, Wong, MK, Migden, MR, Sharma, P, Myers, JN, Gross, N, Amit, M. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precision Oncology 7:e2200490, 2023. e-Pub 2023. PMID: 37285560.
- Zhang X, Gleber-Netto FO, Wang S, Martins-Chaves RR, Gomez RS, Vigneswaran N, Sarkar A, William WN, Papadimitrakopoulou V, Williams M, Bell D, Palsgrove D, Bishop J, Heymach JV, Gillenwater AM, Myers JN, Ferrarotto R, Lippman SM, Pickering CR, Xiao G. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Cancer Med 12(6):7508-7518, 2023. e-Pub 2023. PMID: 36721313.
- Chahoud J, Zacharias NM, Pham R, Qiao W, Guo M, Lu X, Alaniz A, Segarra L, Martinez-Ferrer M, Gleber-Netto FO, Pickering CR, Rao P, Pettaway CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up. Cancers (Basel) 14(24), 2022. e-Pub 2022. PMID: 36551510.
- Brenes DR, Nipper AJ, Tan MT, Gleber-Netto FO, Schwarz RA, Pickering CR, Williams MD, Vigneswaran N, Gillenwater AM, Sikora AG, Richards-Kortum RR. Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions. Oral Oncol 135:106232, 2022. e-Pub 2022. PMID: 36335817.
- Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader ME, Raza SM, DeMonte F. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res 41(1):292, 2022. e-Pub 2022. PMID: 36195959.
- Michikawa C, Gopalakrishnan V, Harrandah AM, Karpinets TV, Garg RR, Chu RA, Park YP, Chukkapallia SS, Yadlapalli N, Erikson-Carter KC, Gleber-Netto FO, Sayour E, Progulske-Fox A, Chan EKL, Wu X, Zhang J, Jobin C, Wargo JA, Pickering CR, Myers JN, Silver N. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1). Neoplasia 31:100813, 2022. e-Pub 2022. PMID: 35834946.
- Shi Y, Xie T, Wang B, Wang R, Cai Y, Yuan B, Gleber-Netto FO, Tian X, Rodriguez-Rosario AE, Osman AA, Wang J, Pickering CR, Ren X, Sikora AG, Myers JN, Rangel R. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Commun Biol 5(1):757, 2022. e-Pub 2022. PMID: 35902768.
- Le X, Gleber-Netto FO, Rubin ML, Qing Y, Du R, Kies M, Blumenschein G, Lu C, Johnson FM, Bell D, Lewis J, Zhang J, Feng L, Wilson K, Marcelo-Lewis K, Wang J, Ginsberg L, Gillison M, Lee JJ, Meric-Bernstam F, Mills GB, William WN, Myers JN, Pickering CR. Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection. Clin Cancer Res 28(13):2796-2806, 2022. e-Pub 2022. PMID: 35443062.
- Gomes NA, do Valle IB, Gleber-Netto FO, Silva TA, Oliveira HMC, de Oliveira RF, Ferreira LAQ, Castilho LS, PHRG R, PHDM P, Menezes GB, de Magalhães CS, Mesquita RA, Marques MM, Birbrair A, Diniz IMA. Nestin and NG2 transgenes reveal two populations of perivascular cells stimulated by photobiomodulation. J Cell Physiol 237(4):2198-2210, 2022. e-Pub 2022. PMID: 35040139.
- Amit M, Liu C, Mansour J, Gleber-Netto FO, Tam S, Baruch EN, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Tsai K, Flores ER, Migden MR, Silverman DA, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer 127(23):4413-4420, 2021. e-Pub 2021. PMID: 34358340.
- Gorur A, Patiño M, Shi T, Corrales G, Takahashi H, Rangel R, Gleber-Netto FO, Pickering C, Myers JN, Cata JP. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. J Cell Physiol 236(11):7698-7710, 2021. e-Pub 2021. PMID: 34038587.
- Gorur A, Patiño M, Takahashi H, Corrales G, Pickering CR, Gleber-Netto FO, Myers JN, Cata JP. Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma. Life Sci 278:119541, 2021. e-Pub 2021. PMID: 33930368.
- Lindemann A, Patel AA, Tang L, Tanaka N, Gleber-Netto FO, Bartels MD, Wang L, McGrail DJ, Lin SY, Frank SJ, Frederick MJ, Myers JN, Osman AA. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Mol Cancer Ther 20(7):1257-1269, 2021. e-Pub 2021. PMID: 33947685.
- Chahoud J, Gleber-Netto FO, McCormick BZ, Rao P, Lu X, Guo M, Morgan MB, Chu RA, Martinez-Ferrer M, Eterovic AK, Pickering CR, Pettaway CA. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 27(9):2560-2570, 2021. e-Pub 2021. PMID: 33441293.
- Amit M, Liu C, Gleber-Netto FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch EN, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer 127(8):1238-1245, 2021. e-Pub 2021. PMID: 33320343.
- Amit, M, Liu, C, Netto, FG, Kini, S, Tam, S, Benov, A, Aashiq, M, El-Naggar, AK, Moreno, AC, Rosenthal, D, Glisson, BS, Ferrarotto, R, Wong, MK, Migden, MR, Li, G, Khanna, A, Goepfert, RP, Nagarajan, P, Weber, RS, Myers, JN, Gross, N. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. European Journal of Cancer 144:169-177, 2021. e-Pub 2021. PMID: 33352413.
- Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton J, Sikora AG, Myers JN, Pickering CR. Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis. JCI Insight 5(23), 2020. e-Pub 2020. PMID: 33108350.
- Facompre ND, Rajagopalan P, Sahu V, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Weinstein GS, Jalaly J, Lin A, Rustgi AK, Nakagawa H, Califano JA, Pickering CR, White EA, Windle BE, Morgan IM, Cohen RB, Gimotty PA, Basu D. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. Int J Cancer 147(11):3236-3249, 2020. e-Pub 2020. PMID: 32478869.
- Gleber-Netto FO, Neskey D, Costa AFM, Kataria P, Rao X, Wang J, Kowalski LP, Pickering CR, Dias-Neto E, Myers JN. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Cancer 126(20):4498-4510, 2020. e-Pub 2020. PMID: 32797678.
- Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JN. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578(7795):449-454, 2020. e-Pub 2020. PMID: 32051587.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol 97:56-61, 2019. e-Pub 2019. PMID: 31421472.
- Ishikawa S, Wong DTW, Sugimoto M, Gleber-Netto FO, Li F, Tu M, Zhang Y, Akin D, Iino M. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions. Clin Oral Investig 23(9):3557-3563, 2019. e-Pub 2019. PMID: 30539290.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head Neck 41(8):2688-2695, 2019. e-Pub 2019. PMID: 30932264.
- Garcia-Rosa S, Trivella DB, Marques VD, Serafim RB, Pereira JG, Lorenzi JC, Molfetta GA, Christo PP, Olival GS, Marchitto VB, Brum DG, Sabedot TS, Noushmehr H, Farias AS, Santos LM, Nogueira-Machado JA, Souza JE, Romano CM, Conde RM, Santos AC, Guerreiro CT, Schreuder WH, Gleber-Netto FO, Amorim M, Valieris R, Silva ITD, Silva WA, Nunes DN, Oliveira PS, Valente V, Arruda MA, Hill SJ, Barreira AA, Dias-Neto E. A non-functional galanin receptor-2 in a multiple sclerosis patient. Pharmacogenomics J 19(1):72-82, 2019. e-Pub 2019. PMID: 30131588.
- Gleber-Netto FO, Rao X, Guo T, Xi Y, Gao M, Shen L, Erikson K, Kalu NN, Ren S, Xu G, Fisch KM, Akagi K, Seiwert T, Gillison M, Frederick MJ, Johnson FM, Wang J, Myers JN, Califano J, Skinner HD, Pickering CR. Variations in HPV function are associated with survival in squamous cell carcinoma. JCI Insight 4(1), 2019. e-Pub 2019. PMID: 30626753.
- Kaczor-Urbanowicz KE, Trivedi HM, Lima PO, Camargo PM, Giannobile WV, Grogan TR, Gleber-Netto FO, Whiteman Y, Li F, Lee HJ, Dharia K, Aro K, Martin Carreras-Presas C, Amuthan S, Vartak M, Akin D, Al-Adbullah H, Bembey K, Klokkevold PR, Elashoff D, Barnes VM, Richter R, DeVizio W, Masters JG, Wong DTW. Salivary exRNA biomarkers to detect gingivitis and monitor disease regression. J Clin Periodontol 45(7):806-817, 2018. e-Pub 2018. PMID: 29779262.
- Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S, Myers JN, Pickering CR. High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma. Clin Cancer Res 24(7):1727-1733, 2018. e-Pub 2018. PMID: 29330202.
- Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR, Head, Supplement Consortium NCSPORE(HIV(. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124(1):84-94, 2018. e-Pub 2018. PMID: 29053175.
- Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson F, Gleber-Netto FO, Fu S, Kimmel M, Wang J, Hittelman WN, Pickering CR, Myers JN, Osman AA. Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation. Clin Cancer Res 23(21):6541-6554, 2017. e-Pub 2017. PMID: 28790110.
- Kalu NN, Mazumdar T, Peng S, Shen L, Sambandam V, Rao X, Xi Y, Li L, Qi Y, Gleber-Netto FO, Patel A, Wang J, Frederick MJ, Myers JN, Pickering CR, Johnson FM. Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget 8(49):86369-86383, 2017. e-Pub 2017. PMID: 29156801.
- Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao HK, Chang YL, Chang KP, Wong DT. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population. Clin Cancer Res 22(13):3340-7, 2016. e-Pub 2016. PMID: 26847061.
- Thomas AM, Gleber-Netto FO, Fernandes GR, Amorim M, Barbosa LF, Francisco AL, de Andrade AG, Setubal JC, Kowalski LP, Nunes DN, Dias-Neto E. Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms. BMC Microbiol 14(1):250, 2014. e-Pub 2014. PMID: 25278091.
- do Carmo MA, Gleber-Netto FO, Romano ML, Caldeira PC, de Aguiar MC. Clinical and demographic overlaps among immunologically mediated oral diseases: a challenge for clinicians. Gen Dent 62(1):67-72, 2014. e-Pub 2014. PMID: 24401354.
- Bernardes VF, Gleber-Netto FO, Sousa SF, Rocha RM, Aguiar MC. EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study. BMJ Open 3(1), 2013. e-Pub 2013. PMID: 23358562.
- de Sousa SF, Gleber-Netto FO, de Oliveira-Neto HH, Batista AC, Nogueira Guimarães Abreu MH, de Aguiar MC. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. Appl Immunohistochem Mol Morphol 20(6):588-94, 2012. e-Pub 2012. PMID: 22495364.
- Ribeiro DC, Gleber-Netto FO, Sousa SF, Bernardes VD, Guimarães-Abreu MH, Aguiar MC. Immunohistochemical expression of EGFR in oral leukoplakia: association with clinicopathological features and cellular proliferation. Med Oral Patol Oral Cir Bucal 17(5):e739-44, 2012. e-Pub 2012. PMID: 22322523.
- Gleber-Netto FO, Florêncio TN, de Sousa SF, Abreu MH, Mendonça EF, Aguiar MC. Angiogenesis and lymphangiogenesis in mucoepidermoid carcinoma of minor salivary glands. J Oral Pathol Med 41(8):603-9, 2012. e-Pub 2012. PMID: 22582704.
- Oliveira-Neto HH, Gleber-Netto FO, de Sousa SF, França CM, Aguiar MC, Silva TA, Batista AC. A comparative study of microvessel density in squamous cell carcinoma of the oral cavity and lip. Oral Surg Oral Med Oral Pathol Oral Radiol 113(3):391-8, 2012. e-Pub 2012. PMID: 22669145.
- Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Abreu MH, Aguiar MC. EGF in saliva and tumor samples of oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol 19(6):528-33, 2011. e-Pub 2011. PMID: 21436680.
- Netto FO, Diniz IM, Grossmann SM, de Abreu MH, do Carmo MA, Aguiar MC. Risk factors in burning mouth syndrome: a case-control study based on patient records. Clin Oral Investig 15(4):571-5, 2011. e-Pub 2011. PMID: 20440632.
- Alves, CM, Netto, FG, De Sousa, SF, Bernardes, VF, De Aguiar, MF. Oral squamous cell carcinoma: Relation between histopathologic graduation and clinical features of the neoplasia. Pesquisa Brasileira em Odontopediatria e Clinica Integrada 11(4):485-489, 2011. e-Pub 2011.
- Gleber-Netto FO, Diniz IM, Mudado FA, Fraga MG, Vargas AM. Assessment of aesthetic perception of mild and moderate dental fluorosis levels among students from the Federal University of Minas Gerais-UFMG, Brazil. Oral Health Prev Dent 9(4):339-45, 2011. e-Pub 2011. PMID: 22238732.
- Grossmann Sde M, Teixeira R, Oliveira GC, Gleber-Netto FO, Araújo FM, Araújo FM, Carmo MA. Xerostomia, hyposalivation and sialadenitis in patients with chronic hepatitis C are not associated with the detection of HCV RNA in saliva or salivary glands. J Clin Pathol 63(11):1002-7, 2010. e-Pub 2010. PMID: 20924089.
- Netto, FOG, Diniz, IMA, Grossmann, SMC, Carmo, MAV, Aguiar, MCF. Burning mouth syndrome: clinical characteristics, etiological factors and treatment. Revista Cubana de Estomatologia 47(4):417-427, 2010. e-Pub 2010.
- Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Aguiar MC. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study. J Exp Clin Cancer Res 29(1):40, 2010. e-Pub 2010. PMID: 20429940.
Review Articles
- Jones, GH, Anderson, J, Nguyen, TP, Gleber-Netto, FO, Hwang, WL, Puduvalli, VK, Monje, M, Amit, M. Novel approaches to clinical trial design in cancer neuroscience. Neuron 113(17):2791-2813, 2025. e-Pub 2025. PMID: 40907474.
- Yaniv D, Mattson B, Talbot S, Gleber-Netto FO, Amit M. Targeting the peripheral neural-tumour microenvironment for cancer therapy. Nat Rev Drug Discov 23(10):780-796, 2024. e-Pub 2024. PMID: 39242781.
- Chiamulera MMA, Zancan CB, Remor AP, Cordeiro MF, Gleber-Netto FO, Baptistella AR. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis. BMC Cancer 21(1):205, 2021. e-Pub 2021. PMID: 33639868.
- Gleber-Netto FO, Braakhuis BJ, Triantafyllou A, Takes RP, Kelner N, Rodrigo JP, Strojan P, Vander Poorten V, Rapidis AD, Rinaldo A, Brakenhoff RH, Ferlito A, Kowalski LP. Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor. Oral Oncol 51(8):738-44, 2015. e-Pub 2015. PMID: 25987307.
- Netto, FG, Diniz, IA, Grossmann, SC, do Carmo, MV, De Aguiar, MF. Síndrome de ardor bucal: aspectos clínicos, etiopatogenia y tratamiento. Revista Cubana de Estomatologia 47(4):417-427, 2010. e-Pub 2010.
Abstracts
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Su SY, Hanna EY. Identification of Signaling Pathways Associated with Resistance to Induction Chemotherapy in Sinonasal Undifferentiated Carcinoma 86(S01):S576, 2025. e-Pub 2025.
- Bita Esmaeli, Gleber-Netto FO, Oded Sagiv, Curtis Pickering, Neil Gross, Jing Ning, Melisachew Yeshi, Yonas Mitku, Priyadharsini Nagarajan. Genomic and Immunophenotypic Characteristics of Conjunctival Squamous Cell Carcinoma in a Sub-Saharan African Cohort Suggest a Role for Immune Checkpoint Inhibitors in Locally Advanced or Metastatic Patients. The 12th Annual Symposium on Global Cancer Research 10:85-86, 2024. e-Pub 2024.
- Bita Esmaeli, Gleber-Netto FO, Oded Sagiv, Curtis R. Pickering, Neil Gross, Jing Ning, Melisachew M. Yeshi, Jonas Mitku, Michael T. Tetzlaff, Priyadharsini Nagarajan. Abstract 2501: High mutation burden and ultraviolet light signature in conjunctival squamous cell carcinoma. AACR Annual Meeting 2024 84(6_Supplement):2501, 2024. e-Pub 2024.
- Shamima Akhter, Tongxin Xie, Simone Anfossi, Adewale Adebayo, Gleber-Netto FO, Melanie Winkle, Masayoshi Shimitzu, Weilu Zhao, Megan L. Uhelski, Yan Li, George A. Calin, Moran Amit. Abstract PO-068: Harmony between transdifferentiated neuron and immunosuppressive tumor microenvironment. AACR-AHNS Head and Neck Cancer Conference 29((18_Supplement)), 2023. e-Pub 2023.
- Mica D. E. Glaun, Gleber-Netto FO, Priyadharsini Nagarajan, Tongxin Xie, Shamima Akhter, Yu Han Chen;, Erez Baruch N. Baruch, Michael K. Wong, Emily Y. Chu, Kenneth Y. Tsai, Elsa R. Flores, Deborah A. Silverman, Ryan P. Goepfert, Murat Cobanoglu, Jared Burks, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross, Moran Amit. Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma. AACR-AHNS Head and Neck Cancer Conference 29((18_Supplement)), 2023. e-Pub 2023.
- Deborah A. Silverman, Shamima Akhter, Tongxin Xie, Shajedul Islam, Simone Anfossi, Jennifer D. Covello, Gleber-Netto FO, Elien Doorduijn, Yunfei Wang, Emily L. Ashkin, Jeffrey N. Myers, George A. Calin, Patrick Hwu, Moran Amit. Abstract PO-076: Adrenergic regulation of the anti-tumor immune response in p53-deficient tumors. AACR-AHNS Head and Neck Cancer Conference 29((18_Supplement)), 2023. e-Pub 2023.
- Shajedul Islam, Gleber-Netto FO, Collin F. Mulcahy, Mica D. E. Glaun, Patrick J. Hunt, Michelle D. Williams, Carly E. Barbon, Weilu Zhao, Adewale Adebayo, Shamima Akhter, Tongxin Xie, Ismail Yaman, Jared K. Burks, Javier Gomez, Karin Woodman, Teresa E. Lever, Katherine A. Hutcheson, Moran Amit. Abstract PO-049: The neural landscape is associated with functional outcomes for patients with oropharyngeal squamous cell carcinoma. AACR-AHNS Head and Neck Cancer Conference 29((18_Supplement)), 2023. e-Pub 2023.
- Mei Zhao, Tianxiao Wang, Gleber-Netto FO, Zhen Chen, Daniel J. McGrail, Javier A. Gomez, Wutong Ju, Mayur A. Gadhikar, Wencai Ma, Li Shen, Ximing Tang, Sen Pathak, Maria G. Raso, Jared Burks, Shiaw-Yih Lin, Jing Wang, Asha S. Multani, Curtis R. Pickering, Junjie Chen, Jeffrey N. Myers, Ge Zhou. Abstract 2585: Mutant p53 gains oncogenic functions through a cytosolic DNA response. AACR Annual Meeting 2023 83(7_Supplement):2585, 2023. e-Pub 2023.
- Nagarajan P, lt, Gleber-Netto B, lt, /b>, Parra E, Pickering C, Davies M, Aung P, Cho WC, Torres-Cabala C, Curry J, Ivan D, Prieto V, Pettaway C. Exploratory Analyses of Tumor-Infiltrating Inflammatory Cells in Male Genitourinary Melanoma. Laboratory Investigation 102(1), 2021. e-Pub 2021.
- Takahashi Y, Amit M, Gleber-Netto FO, Silverman D, Bell D, Xie T, Roberts D, Myers JN, Hanna EY. Evaluation of the Immune Microenvironment in Sinonasal Squamous Cell Carcinoma and Its Association with Patients' Survival. J Neurol Surg B Skull Base 82(2), 2021. e-Pub 2021.
- Takahashi Y, Takahashi H, Amit M, Gleber-Netto FO, Bell D, Xie T, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Overcoming cisplatin resistance in sinonasal undifferentiated carcinoma by inhibiting the TGFβ signaling pathway in vivo. Clin Cancer Res 26(12), 2020. e-Pub 2020.
- Gleber-Netto FO, Gao M, Shen L, Wang J, Myers JN, Johnson FM, Pickering CR. Variations in the proteasome activity are associated with human papilloma virus (HPV) gene expression and patient survival in HPV+ oropharyngeal tumors. Clin Cancer Res 26(12), 2020. e-Pub 2020.
- Facompre ND, Rajagopalan P, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Nakagawa H, White EA, Rustgi AK, Califano JA, Pickering CR, Windle B, Morgan IM, Gimotty PA, Basu D. HPV+ oral cancer PDXs identify prognostic utility for E2F target gene expression and mutation burden. Clin Cancer Res 26(12), 2020. e-Pub 2020.
- Facompre ND, Rajagopalan P, Sahu V, Gleber-Netto FO, Califano JA, Pickering CR, Gimotty PA, Basu D. Predictors of HPV-related head and neck cancer progression identified through patient-derived models. Cancer Res 80(11), 2020. e-Pub 2020.
- Facompre ND, Rajagopalan P, Sahu V, Gleber-Netto FO, Califano JA, Pickering CR, Gimotty PA, Basu D. Abstract A03: Predictors of HPV-related head and neck cancer progression identified through patient-derived models. AACR Special Conference on the Evolving Landscape of Cancer Modeling 80(11_Supplement):A03, 2020. e-Pub 2020.
- Takahashi Y, Takahashi H, Amit M, Gleber-Netto FO, Bell D, Xie T, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Abstract B08: Overcoming cisplatin resistance in sinonasal undifferentiated carcinoma by inhibiting the TGFβ signaling pathway in vivo. AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research 26(12_Supplement_2):B08, 2020. e-Pub 2020.
- Gleber-Netto FO, Gao M, Shen L, Wang J, Myers JN, Johnson FM, Pickering CR. Abstract B14: Variations in the proteasome activity are associated with human papilloma virus (HPV) gene expression and patient survival in HPV+ oropharyngeal tumors. AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research 26(12_Supplement_2):B14, 2020. e-Pub 2020.
- Facompre ND, Rajagopalan P, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Nakagawa H, White EA, Rustgi AK, Califano JA, Pickering CR, Windle B, Morgan IM, Gimotty PA, Basu D. Abstract A01: HPV+ oral cancer PDXs identify prognostic utility for E2F target gene expression and mutation burden. AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research 26(12_Supplement_2):A01, 2020. e-Pub 2020.
- Chahoud J, Netto F, Segura RL, Parrra Cuentes ER, Lu X, MD Priya Rao MD, Wistuba II, Pickering CR, Pettaway C. Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches. Journal of Urology 203(4):386, 2020. e-Pub 2020.
- Chahoud J, Pham* R, Guo M, Pickering C, Qiao W, Khanna A, Netto F, Pettaway C, Yao P. A expression and survival outcomes in patients with penile squamous cell carcinoma: The MD Anderson Cancer Center experience. Journal of Clinical Oncology 38(6):5, 2020. e-Pub 2020.
- Gao, Meng, Gleber-Netto FO, Xie T, Vellano CP, Marszalek JR, Pickering CR. An oxidative phosphorylation inhibitor identifies a metabolic vulnerability in human papilloma virus-positive oropharyngeal squamous cell carcinoma. Clinical Cancer Research 26(12):57, 2020. e-Pub 2020.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie T, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Development of Clinically Applicable Molecular Markers Distinguishing Sinonasal Undifferentiated Carcinoma from Sinonasal Squamous Cell Carcinoma. J Neurol Surg B Skull Base 81(S 01), 2020. e-Pub 2020.
- Chahoud J, Netto F, Segura RL, Parra Cuentas ER, Lu X, Rao P, Wistuba II, Pickering CR, Pettaway CA. Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches. 2020 Genitourinary Cancers Symposium 38(Issue 6_suppl), 2020. e-Pub 2020.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie T, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Development of Clinically Applicable Molecular Markers Distinguishing Sinonasal Undifferentiated Carcinoma from Sinonasal Squamous Cell Carcinoma. J Neurol Surg B Skull Base 81(S 01):S1-S272, 2020. e-Pub 2020.
- Gleber-Netto FO, Gao M, Rao X, Vellano CP, Marszalek JR, Wang J, Johnson FM, Pickering CR. Abstract 4942: Variations in HPV function are associated with patient outcome and identify new candidate therapeutic approaches. AACR Annual Meeting 2019 79(13_Supplement):4942, 2019. e-Pub 2019.
- Chahoud J, McCormick BZ, Netto F, Rao P, Pickering CR, Pettaway CA. Penile squamous cell carcinoma is genomically similar to other HPV-driven tumors. Journal of Clinical Oncology 37(7_Supplement), 2019. e-Pub 2019.
- Chahoud J, McCormick BZ, Netto F, Rao P, Pickering CR. Penile squamous cell carcinoma is genomically similar to other HPV-driven tumors. Genitourinary Cancers Symposium 37(7_Supplement), 2019. e-Pub 2019.
- Le X, Pickering CR, M Laura Rubin M, Netto F, Kies MS, Johnson FM, Lu C, Blumenschein GR, Jr, Bell D, Ginsberg LE, Wilson KF, Lewis J, Feng L, Wang J, J Jack Lee J, William WN, Myers J. Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection. Journal of Clinical Oncology 37(15):6067, 2019. e-Pub 2019.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. PFKFB2 as a Potential Survival Marker in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base 80(S 01), 2019. e-Pub 2019.
- McCormick* B, Chahoud J, Netto F, Rao P, Pickering C, Pettaway C. MP73-11: Penile squamous cell carcinoma is genomically similar to other hpv-driven tumors. Journal of Urology 201(4), 2019. e-Pub 2019.
- Basu D, Facompre ND, Gimotty PA, Rajagopalan P, Sahu V, Pearson AT, Califano JA, Netto F, Pickering CR. Identifying adverse molecular features of HPV+ head and neck cancers using patient-derived models. Journal of Clinical Oncology 37(15):6057, 2019. e-Pub 2019.
- Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. PFKFB2 as a Potential Survival Marker in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base 80(S 01):S1-S244, 2019. e-Pub 2019.
- Gleber-Netto FO, Rao X, Erikson K, Akagi K, Johnson FM, Wang J, Califano J, Gillison ML, Myers JN, Pickering CR. Risk stratification and biomarker discovery in HPV-positive oropharynx squamous cell carcinoma determined by HPV and human gene expression profile associations. Cancer Res 78(13_Supplement), 2018. e-Pub 2018.
- Gleber-Netto FO, Rao X, Erikson K, Akagi K, Johnson FM, Wang J, Califano J, Gillison ML, Myers JN, Pickering CR. Abstract 4621: Risk stratification and biomarker discovery in HPV-positive oropharynx squamous cell carcinoma determined by HPV and human gene expression profile associations. Cancer Res 78(13_Supplement):4621, 2018. e-Pub 2018.
- Takahashi Y, Gleber-Netto FO, Bell D, Amit M, Roberts D, Pickering C, Myers JN, Hanna E. Activation of the TGF Beta Signaling Pathway in Nonresponders to Induction Chemotherapy in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base 79(S 01), 2018. e-Pub 2018.
- Takahashi Y, Gleber-Netto FO, Bell D, Amit M, Roberts D, Pickering C, Myers JN, Hanna E. Activation of the TGF Beta Signaling Pathway in Nonresponders to Induction Chemotherapy in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base 79(S 01):S1-S188, 2018. e-Pub 2018.
- Takahashi Y, Bell D, Gleber-Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Identification of gene expression patterns distinguishing responders and non-responders to induction chemotherapy in sinonasal undifferentiated carcinoma. Clin Cancer Res 23(23_Supplement), 2017. e-Pub 2017.
- Takahashi Y, Bell D, Gleber-Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Abstract 42: Identification of gene expression patterns distinguishing responders and non-responders to induction chemotherapy in sinonasal undifferentiated carcinoma. AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research 23(23_Supplement):42, 2017. e-Pub 2017.
- Takahashi Y, Bell D, Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Gene Expression Signature in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base. Journal of Neurological Surgery 78(S 01), 2017. e-Pub 2017.
- Takahashi Y, Bell D, Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Gene Expression Signature in Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base. Journal of Neurological Surgery 78(S 01):S1-S156, 2017. e-Pub 2017.
- Pizzi MP, Freitas HC, Amorim MG, Figueiredo Barros BDD, Gleber-Netto FO, Mattos Costa AF, Begnami MD, Pelosof AG, Nunes DN, Dias-Neto E. Gastric adenocarcinoma TP53 mutations in an ethnically admixed population. Cancer Res 76(14_Supplement), 2016. e-Pub 2016.
- Pizzi MP, Freitas HC, Amorim MG, Figueiredo Barros BDD, Gleber-Netto FO, Mattos Costa AF, Begnami MD, Pelosof AG, Nunes DN, Dias-Neto E. Abstract 3697: Gastric adenocarcinoma TP53 mutations in an ethnically admixed population. Cancer Res 76(14_Supplement):3697, 2016. e-Pub 2016.
- Thomas AM, Gleber-Netto FO, Amorim MG, Noronha Francisco AL, Carvalho MB, Kowalski LP, Setúbal JC, Nunes DN, Dias-Neto E. OP177. A METAGENOMIC SURVEY OF BACTERIAL POPULATIONS IN ORAL CAVITY CANCER. 5th World Congress of the International Academy of Oral Oncology (IAOO) 37, 2015. e-Pub 2015.
- Gleber-Netto FO, Valieris R, Souza JE, Kowalski LP, GENCAPO, Nunes DN, Neto ED. OP188. SEARCHING FOR LYMPH NODE METASTASIS BIOMARKERS IN ORAL SQUAMOUS CELL CARCINOMA USING LARGE-SCALE TRANSCRIPTIONAL ANALYSIS. 5th World Congress of the International Academy of Oral Oncology (IAOO) 37, 2015. e-Pub 2015.
- Costa AF, Gleber-Netto F, Kelner N, Nunes DN, Paulo L, Kowalski, Dias-Neto E. PP129. NEXT-GENERATION SEQUENCING OF TP53 IN ORAL SQUAMOUS CELL CARCINOMA: PROGNOSTIC IMPLICATIONS. 5th World Congress of the International Academy of Oral Oncology (IAOO) 37, 2015. e-Pub 2015.
- Gleber-Netto FO, Guedes Florencio TN, Sousa SF, Mendonc EF, #807, a, Gomes CC, Ferreira Aguiar MC. Angiogenesis and lymphangiogenesis in mucoepidermoid carcinoma of the minor salivary glands. Cancer Res 71(8_Supplement), 2011. e-Pub 2011.
- Sousa SF, Gleber-Netto FO, Oliveira-Neto HH, Batista AC, Gomes CC, Gomez RS, F Aguiar MC. Lymphatic vessels and neoformed microvessels density in primary oral squamous cell carcinoma and associated lymph nodes. Cancer Res 71(8_Supplement), 2011. e-Pub 2011.
- Gleber-Netto FO, Guedes Florencio TN, Sousa SF, Mendonça EF, Gomes CC, Ferreira Aguiar MC. Abstract LB-289: Angiogenesis and lymphangiogenesis in mucoepidermoid carcinoma of the minor salivary glands. Cancer Res 71(8_Supplement):LB-289, 2011. e-Pub 2011.
- Sousa SF, Gleber-Netto FO, Oliveira-Neto HH, Batista AC, Gomes CC, Gomez RS, F Aguiar MC. Abstract LB-373: Lymphatic vessels and neoformed microvessels density in primary oral squamous cell carcinoma and associated lymph nodes. Cancer Res 71(8_Supplement):LB-373, 2011. e-Pub 2011.
Patient Reviews
CV information above last modified March 24, 2026